184 related articles for article (PubMed ID: 37942319)
1. Cattle-derived knob paratopes grafted onto peripheral loops of the IgG1 Fc region enable the generation of a novel symmetric bispecific antibody format.
Yanakieva D; Vollmer L; Evers A; Siegmund V; Arras P; Pekar L; Doerner A; Valldorf B; Kolmar H; Zielonka S; Krah S
Front Immunol; 2023; 14():1238313. PubMed ID: 37942319
[TBL] [Abstract][Full Text] [Related]
2. Bovine ultralong CDR-H3 derived knob paratopes elicit potent TNF-α neutralization and enable the generation of novel adalimumab-based antibody architectures with augmented features.
Arras P; Zimmermann J; Lipinski B; Valldorf B; Evers A; Elter D; Krah S; Doerner A; Guarnera E; Siegmund V; Kolmar H; Pekar L; Zielonka S
Biol Chem; 2024 Feb; ():. PubMed ID: 38373142
[TBL] [Abstract][Full Text] [Related]
3. Grabbing the Bull by Both Horns: Bovine Ultralong CDR-H3 Paratopes Enable Engineering of 'Almost Natural' Common Light Chain Bispecific Antibodies Suitable For Effector Cell Redirection.
Klewinghaus D; Pekar L; Arras P; Krah S; Valldorf B; Kolmar H; Zielonka S
Front Immunol; 2021; 12():801368. PubMed ID: 35087526
[TBL] [Abstract][Full Text] [Related]
4. Serum albumin binding knob domains engineered within a V
Adams R; Joyce C; Kuravskiy M; Harrison K; Ahdash Z; Balmforth M; Chia K; Marceddu C; Coates M; Snowden J; Goursaud E; Ménochet K; van den Elsen J; Payne RJ; Lawson ADG; Scott-Tucker A; Macpherson A
Front Immunol; 2023; 14():1170357. PubMed ID: 37251411
[TBL] [Abstract][Full Text] [Related]
5. Milking the Cow: Cattle-Derived Chimeric Ultralong CDR-H3 Antibodies and Their Engineered CDR-H3-Only Knobbody Counterparts Targeting Epidermal Growth Factor Receptor Elicit Potent NK Cell-Mediated Cytotoxicity.
Pekar L; Klewinghaus D; Arras P; Carrara SC; Harwardt J; Krah S; Yanakieva D; Toleikis L; Smider VV; Kolmar H; Zielonka S
Front Immunol; 2021; 12():742418. PubMed ID: 34759924
[TBL] [Abstract][Full Text] [Related]
6. The proximity of the N- and C- termini of bovine knob domains enable engineering of target specificity into polypeptide chains.
Hawkins A; Joyce C; Brady K; Hold A; Smith A; Knight M; Howard C; van den Elsen J; Lawson ADG; Macpherson A
MAbs; 2022; 14(1):2076295. PubMed ID: 35634719
[TBL] [Abstract][Full Text] [Related]
7. Influence of the bispecific antibody IgG subclass on T cell redirection.
Kapelski S; Cleiren E; Attar RM; Philippar U; Häsler J; Chiu ML
MAbs; 2019; 11(6):1012-1024. PubMed ID: 31242061
[TBL] [Abstract][Full Text] [Related]
8. Selection of bispecific antibodies with optimal developability using FcRn‑Ph‑HPLC as an optimized FcRn affinity chromatography method.
Müller T; Tasser C; Tesar M; Fucek I; Schniegler-Mattox U; Koch J; Ellwanger K
MAbs; 2023; 15(1):2245519. PubMed ID: 37599441
[TBL] [Abstract][Full Text] [Related]
9. Antiparallel conformation of knob and hole aglycosylated half-antibody homodimers is mediated by a CH2-CH3 hydrophobic interaction.
Elliott JM; Ultsch M; Lee J; Tong R; Takeda K; Spiess C; Eigenbrot C; Scheer JM
J Mol Biol; 2014 May; 426(9):1947-57. PubMed ID: 24576605
[TBL] [Abstract][Full Text] [Related]
10. Full-length recombinant antibodies from
Rashid MH
MAbs; 2022; 14(1):2111748. PubMed ID: 36018829
[TBL] [Abstract][Full Text] [Related]
11. Engineering therapeutic bispecific antibodies using CrossMab technology.
Klein C; Schaefer W; Regula JT; Dumontet C; Brinkmann U; Bacac M; Umaña P
Methods; 2019 Feb; 154():21-31. PubMed ID: 30453028
[TBL] [Abstract][Full Text] [Related]
12. Structural differences between glycosylated, disulfide-linked heterodimeric Knob-into-Hole Fc fragment and its homodimeric Knob-Knob and Hole-Hole side products.
Kuglstatter A; Stihle M; Neumann C; Müller C; Schaefer W; Klein C; Benz J;
Protein Eng Des Sel; 2017 Sep; 30(9):649-656. PubMed ID: 28985438
[TBL] [Abstract][Full Text] [Related]
13. Modular design of bi- and multi-specific knob domain fusions.
Kuravsky M; Gibbons GF; Joyce C; Scott-Tucker A; Macpherson A; Lawson ADG
Front Immunol; 2024; 15():1384467. PubMed ID: 38605965
[TBL] [Abstract][Full Text] [Related]
14. The smallest functional antibody fragment: Ultralong CDR H3 antibody knob regions potently neutralize SARS-CoV-2.
Huang R; Warner Jenkins G; Kim Y; Stanfield RL; Singh A; Martinez-Yamout M; Kroon GJ; Torres JL; Jackson AM; Kelley A; Shaabani N; Zeng B; Bacica M; Chen W; Warner C; Radoicic J; Joh J; Dinali Perera K; Sang H; Kim T; Yao J; Zhao F; Sok D; Burton DR; Allen J; Harriman W; Mwangi W; Chung D; Teijaro JR; Ward AB; Dyson HJ; Wright PE; Wilson IA; Chang KO; McGregor D; Smider VV
Proc Natl Acad Sci U S A; 2023 Sep; 120(39):e2303455120. PubMed ID: 37722054
[TBL] [Abstract][Full Text] [Related]
15. Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics.
Asano R; Shimomura I; Konno S; Ito A; Masakari Y; Orimo R; Taki S; Arai K; Ogata H; Okada M; Furumoto S; Onitsuka M; Omasa T; Hayashi H; Katayose Y; Unno M; Kudo T; Umetsu M; Kumagai I
MAbs; 2014; 6(5):1243-54. PubMed ID: 25517309
[TBL] [Abstract][Full Text] [Related]
16. A new approach for generating bispecific antibodies based on a common light chain format and the stable architecture of human immunoglobulin G
De Nardis C; Hendriks LJA; Poirier E; Arvinte T; Gros P; Bakker ABH; de Kruif J
J Biol Chem; 2017 Sep; 292(35):14706-14717. PubMed ID: 28655766
[TBL] [Abstract][Full Text] [Related]
17. A Novel Dual-Fc Bispecific Antibody with Enhanced Fc Effector Function.
Zhou F; Ben Y; Jiang H; Tan S; Mu G; Zha Z; Dong S; Huang S; Zhou Y; Jin Y; Chiu ML
Biochemistry; 2024 Apr; 63(8):958-968. PubMed ID: 38426700
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies.
Skegro D; Stutz C; Ollier R; Svensson E; Wassmann P; Bourquin F; Monney T; Gn S; Blein S
J Biol Chem; 2017 Jun; 292(23):9745-9759. PubMed ID: 28450393
[TBL] [Abstract][Full Text] [Related]
19. A novel glycoengineered bispecific antibody format for targeted inhibition of epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor type I (IGF-1R) demonstrating unique molecular properties.
Schanzer JM; Wartha K; Croasdale R; Moser S; Künkele KP; Ries C; Scheuer W; Duerr H; Pompiati S; Pollman J; Stracke J; Lau W; Ries S; Brinkmann U; Klein C; Umana P
J Biol Chem; 2014 Jul; 289(27):18693-706. PubMed ID: 24841203
[TBL] [Abstract][Full Text] [Related]
20. CDR loop interactions can determine heavy and light chain pairing preferences in bispecific antibodies.
Fernández-Quintero ML; Kroell KB; Grunewald LJ; Fischer AM; Riccabona JR; Liedl KR
MAbs; 2022; 14(1):2024118. PubMed ID: 35090383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
